Eidos Therapeutics (EIDX) PT Raised to $50 at BMO Capital
Tweet Send to a Friend
BMO Capital analyst George Farmer raised the price target on Eidos Therapeutics (NASDAQ: EIDX) to $50.00 (from $40.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
